↓ Skip to main content

Malaria treatment policies and drug efficacy in Haiti from 1955-2012

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, November 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Malaria treatment policies and drug efficacy in Haiti from 1955-2012
Published in
Journal of Pharmaceutical Policy and Practice, November 2013
DOI 10.1186/2052-3211-6-10
Pubmed ID
Authors

Michael E von Fricken, Thomas A Weppelmann, Jennifer D Hosford, Alexander Existe, Bernard A Okech

Abstract

Chloroquine (CQ), after 67 years of use in Haiti, is still part of the official treatment policy for malaria. Several countries around the world have used CQ in the past due to its low incidence of adverse events, therapeutic efficacy, and affordability, but were forced to switch treatment policy due to the development of widespread CQ resistance. The purpose of this paper was to compile literature on malaria treatment policies and antimalarial drug efficacy in Haiti over 67-year period. A systematic review of PubMed, Web of Science, and the Armed Forces Pest Management Board, was conducted to find pertinent documents on national malaria treatment policies and antimalarial drug efficacy studies in Haiti between 1955 and 2012. A total of 329 citations and abstracts were reviewed independently by two researchers, of which thirty three met the final inclusion criteria of studies occurring in Haiti between 1955 and 2012 which specifically discuss malaria treatment policies and drug efficacy. Results suggest that CQ has been the predominant antimalarial drug in use from 1955 to 2012. In 2010 single dose primaquine (PQ) was added to the national treatment policy, however it is not clear whether this new policy has been put into practice. Although no widespread CQ resistance has been reported, some studies have detected low levels of CQ resistance. Increased surveillance and monitoring for CQ resistance should be implemented in Haiti.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 6%
United States 1 6%
Unknown 15 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 29%
Student > Master 5 29%
Professor 2 12%
Student > Ph. D. Student 2 12%
Other 2 12%
Other 1 6%
Readers by discipline Count As %
Agricultural and Biological Sciences 5 29%
Medicine and Dentistry 4 24%
Environmental Science 2 12%
Immunology and Microbiology 2 12%
Economics, Econometrics and Finance 1 6%
Other 1 6%
Unknown 2 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2015.
All research outputs
#2,322,944
of 5,039,712 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#50
of 76 outputs
Outputs of similar age
#44,275
of 108,068 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#3
of 4 outputs
Altmetric has tracked 5,039,712 research outputs across all sources so far. This one has received more attention than most of these and is in the 51st percentile.
So far Altmetric has tracked 76 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,068 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.